2019 annual financial data

Amphastar Pharmaceuticals, Inc. 2019 Operating margin

Amphastar Pharmaceuticals, Inc. 2019 operating margin with verified reported va…

Direct answer

Operating margin was -0.01%.

Operating income was -39,000 USD and net income was 48,939,000 USD.
Operating cash flow was 41,762,000 USD.

Get free Amphastar Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
322,357,000 USD
Operating income
-39,000 USD
Net income
48,939,000 USD
Operating cash flow
41,762,000 USD